Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2026 Financial Results; Highlights Key Regulatory and Clinical Milestones Across Broad, Diverse Pipeline

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/11/2026

1. RKLB
2. ACVA
3. SPY
4. CRWV
5. RIOT
6. RPD
7. NVDA
8. HIMS
9. FERG
10. BBIO

Go back to Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2026 Financial Results; Highlights Key Regulatory and Clinical Milestones Across Broad, Diverse Pipeline

Merck (MRK) Tops Q2 EPS by 14c, Beats on Revenue; Offers FY26 EPS Guidance

August 4, 2026 6:33 AM EDT

Merck (NYSE: MRK) reported Q2 EPS of ($0.13), $0.14 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $16.6 billion versus the consensus estimate of $16.41 billion.

GUIDANCE:

Merck sees FY2026 EPS of $2.66-$2.76, versus the consensus of $2.76.

For earnings history and earnings-related data on Merck (MRK) click here.

... More